These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15857146)

  • 101. Synthesis of a beta-tetrapeptide analog as a mother compound for the development of matrix metalloproteinase-2-imaging agents.
    Mukai T; Suganuma N; Soejima K; Sasaki J; Yamamoto F; Maeda M
    Chem Pharm Bull (Tokyo); 2008 Mar; 56(3):260-5. PubMed ID: 18310933
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Novel Potent Proline-Based Metalloproteinase Inhibitors: Design, (Radio)Synthesis, and First in Vivo Evaluation as Radiotracers for Positron Emission Tomography.
    Kalinin DV; Wagner S; Riemann B; Hermann S; Schmidt F; Becker-Pauly C; Rose-John S; Schäfers M; Holl R
    J Med Chem; 2016 Oct; 59(20):9541-9559. PubMed ID: 27696839
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Matrix metalloproteinase inhibitors: new challenges in the era of post broad-spectrum inhibitors.
    Nuti E; Tuccinardi T; Rossello A
    Curr Pharm Des; 2007; 13(20):2087-100. PubMed ID: 17627541
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Development of matrix metalloproteinase-targeted probes for lung inflammation detection with positron emission tomography.
    Kondo N; Temma T; Aita K; Shimochi S; Koshino K; Senda M; Iida H
    Sci Rep; 2018 Jan; 8(1):1347. PubMed ID: 29358724
    [TBL] [Abstract][Full Text] [Related]  

  • 105. In silico evaluation of new mangiferin-based Positron Emission Tomography radiopharmaceuticals through the inhibition of metalloproteinase-9.
    Gálvez-Rodríguez A; Ferino-Pérez A; Rodríguez-Riera Z; Guerra IR; Jáuregui-Haza UJ
    J Mol Graph Model; 2023 Nov; 124():108569. PubMed ID: 37487370
    [TBL] [Abstract][Full Text] [Related]  

  • 106. The development of a potential single photon emission computed tomography (SPECT) imaging agent for the corticotropin-releasing hormone receptor type.
    Tian X; Hsin LW; Webster EL; Contoreggi C; Chrousos GP; Gold PW; Habib K; Ayala A; Eckelman WC; Jacobson AE; Rice KC
    Bioorg Med Chem Lett; 2001 Feb; 11(3):331-3. PubMed ID: 11212103
    [TBL] [Abstract][Full Text] [Related]  

  • 107. A comprehensive review on controls in molecular imaging: lessons from MMP-2 imaging.
    Lebel R; Lepage M
    Contrast Media Mol Imaging; 2014; 9(3):187-210. PubMed ID: 24700747
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Synthesis of (3) H, (2) H4 and (14) C-SCH 417690 (Vicriviroc).
    Hesk D; Borges S; Hendershot S; Koharski D; McNamara P; Ren S; Saluja S; Truong V; Voronin K
    J Labelled Comp Radiopharm; 2016 May; 59(5):190-6. PubMed ID: 26991320
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Molecular Probes for Imaging Fibrosis and Fibrogenesis.
    Désogère P; Montesi SB; Caravan P
    Chemistry; 2019 Jan; 25(5):1128-1141. PubMed ID: 30014529
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Preface - Matrix metalloproteinases.
    Fridman R
    Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):1925-1926. PubMed ID: 28739264
    [No Abstract]   [Full Text] [Related]  

  • 111. Quantitatively visualizing the activity of MMP-2 enzyme in vivo using a ratiometric photoacoustic probe.
    Yin L; Wang A; Shi H; Gao M
    Methods Enzymol; 2021; 657():59-87. PubMed ID: 34353499
    [TBL] [Abstract][Full Text] [Related]  

  • 112. [Reactions between substituted cyano-acetic acid esters and 1.1-disubstituted semicarbazides].
    Neidlein R; Menche G
    Arch Pharm (Weinheim); 1972 Oct; 305(10):717-24. PubMed ID: 5085525
    [No Abstract]   [Full Text] [Related]  

  • 113. Capping it off.
    Strauss HW
    J Nucl Cardiol; 2009; 16(5):686-8. PubMed ID: 19633901
    [No Abstract]   [Full Text] [Related]  

  • 114. 2-Alkylthio-4-oxo-3-quinazolineacetonitriles and analogous thieno[3,2-d]pyrimidineacetonitriles: reaction with thiols via trapped thioimidates.
    Gütschow M; Powers JC
    J Org Chem; 2001 Jun; 66(13):4723-7. PubMed ID: 11421800
    [No Abstract]   [Full Text] [Related]  

  • 115. Infrared spectra of some decomposition products of four 5,5-disubstituted barbituric acids.
    DANIELSSON B; HANSSON B
    Sven Farm Tidskr; 1961 Jan; 65():4-11. PubMed ID: 13719630
    [No Abstract]   [Full Text] [Related]  

  • 116. [Synthesis of organostannyl barbiturates].
    Maire JC; Van Rietschoten J
    Helv Chim Acta; 1971; 54(4):1054-9. PubMed ID: 5095213
    [No Abstract]   [Full Text] [Related]  

  • 117. [Investigations on the contamination of mebumal with "iso-mebumal"].
    FELUMB R; JERSLEV B; RALD K; RAVN-JONSEN EJ
    Dan Tidsskr Farm; 1960 Sep; 34():174-85. PubMed ID: 13698811
    [No Abstract]   [Full Text] [Related]  

  • 118. Novel Matrix Metalloproteinase-9 (MMP-9) Inhibitors in Cancer Treatment.
    Rashid ZA; Bardaweel SK
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569509
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Systematic Review: Targeted Molecular Imaging of Angiogenesis and Its Mediators in Rheumatoid Arthritis.
    Khodadust F; Ezdoglian A; Steinz MM; van Beijnum JR; Zwezerijnen GJC; Jansen G; Tas SW; van der Laken CJ
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806074
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Towards Optimized Bioavailability of
    Honold L; Austrup M; Faust A; Konken CP; Schwegmann K; Zinnhardt B; Daniliuc CG; Haufe G; Schäfers M; Kopka K; Hermann S
    Mol Imaging Biol; 2022 Jun; 24(3):434-443. PubMed ID: 34750717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.